CDKN1A and ovarian carcinoma: While CAFs-derived exosome microRNA-98-5p (miR-98-5p) can promote CDDP resistance in ovarian cancer by downregulating monoclonal antibody to cyclin-dependent kinase inhibitor 1A (CDKN1A) [101].